|
1
|
Tsushima N, Sakashita T, Homma A,
Hatakeyama H, Kano S, Mizumachi T, Kakizaki T, Suzuki T and Fukuda
S: The role of prophylactic neck dissection and tumor thickness
evaluation for patients with cN0 tongue squamous cell carcinoma.
Eur Arch Otorhinolaryngol. 273:3987–3992. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lao XM, Liang YJ, Su YX, Zhang SE, Zhou XI
and Liao GQ: Distribution and significance of interstitial fibrosis
and stroma-infiltrating B cells in tongue squamous cell carcinoma.
Oncol Lett. 11:2027–2034. 2016.PubMed/NCBI
|
|
3
|
Rao SV Krishna, Mejia G, Roberts-Thomson K
and Logan R: Epidemiology of oral cancer in Asia in the past
decade-an update (2000–2012). Asian Pac J Cancer Prev.
14:5567–5577. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rusthoven K, Ballonoff A, Raben D and Chen
C: Poor prognosis in patients with stage I and II oral tongue
squamous cell carcinoma. Cancer. 112:345–351. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yuen PW, Lam KY, Chan AC, Wei WI and Lam
LK: Clinicopathological analysis of local spread of carcinoma of
the tongue. Am J Surg. 175:242–244. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Regezi JA, Dekker NP, McMillan A,
Ramirez-Amador V, Meneses-Garcia A, Rivera Ruiz-Godoy LM,
Chrysomali E and Ng IO: p53, p21, Rb, and MDM2 proteins in tongue
carcinoma from patients <35 versus >75 years. Oral Oncol.
35:379–383. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Knopf A, Lempart J, Bas M,
Slotta-Huspenina J, Mansour N and Fritsche MK: Oncogenes and tumor
suppressor genes in squamous cell carcinoma of the tongue in young
patients. Oncotarget. 6:3443–3451. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Squarize CH, Castilho RM, Abrahao AC,
Molinolo A, Lingen MW and Gutkind JS: PTEN deficiency contributes
to the development and progression of head and neck cancer.
Neoplasia. 15:461–471. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Voorhoeve PM and Agami R: Classifying
microRNAs in cancer: The good, the bad and the ugly. Biochim
Biophys Acta. 1775:274–282. 2007.PubMed/NCBI
|
|
10
|
Seven M, Karatas OF, Duz MB and Ozen M:
The role of miRNAs in cancer: From pathogenesis to therapeutic
implications. Future Oncol. 10:1027–1048. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sand M, Gambichler T, Sand D, Skrygan M,
Altmeyer P and Bechara FG: MicroRNAs and the skin: Tiny players in
the body's largest organ. J Dermatol Sci. 53:169–175. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yan B, Fu Q, Lai L, Tao X, Fei Y, Shen J,
Chen Z and Wang Q: Downregulation of microRNA 99a in oral squamous
cell carcinomas contributes to the growth and survival of oral
cancer cells. Mol Med Rep. 6:675–681. 2012.PubMed/NCBI
|
|
14
|
Xu P, Guo M and Hay BA: MicroRNAs and the
regulation of cell death. Trends Genet. 20:617–624. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karp X and Ambros V: Developmental
biology. Encountering microRNAs in cell fate signaling. Science.
310:1288–1289. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jin Y, Chen Z, Liu X and Zhou X:
Evaluating the microRNA targeting sites by luciferase reporter gene
assay. Methods Mol Biol. 936:117–127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun Z, Li S, Kaufmann AM and Albers AE:
miR-21 increases the programmed cell death 4 gene-regulated cell
proliferation in head and neck squamous carcinoma cell lines. Oncol
Rep. 32:2283–2289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Su Z, Chen D, Zhang E, Li Y, Yu Z, Shi M,
Jiang Z, Ni L, Yang S, Gui Y, et al: MicroRNA-509-3p inhibits
cancer cell proliferation and migration by targeting the
mitogen-activated protein kinase kinase kinase 8 oncogene in renal
cell carcinoma. Mol Med Rep. 12:1535–1543. 2015.PubMed/NCBI
|
|
20
|
Chen W, Zeng W, Li X, Xiong W, Zhang M,
Huang Y, Zhou L and Jiang S: MicroRNA-509-3p increases the
sensitivity of epithelial ovarian cancer cells to cisplatin-induced
apoptosis. Pharmacogenomics. 17:187–197. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun J, Li J, Zhang W, Zhang J, Sun S, Li
G, Song H and Wan D: MicroRNA-509-3p inhibits cancer cell
proliferation and migration via upregulation of XIAP in gastric
cancer cells. Oncol Res. 25:455–461. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang G, Liu Z, Han Y, Wang X and Yang Z:
Overexpression of miR-509 increases apoptosis and inhibits invasion
via suppression of tumor necrosis factor-a in triple-negative
breast cancer Hs578T cells. Oncol Res. 24:233–238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ulanovski D, Stern Y, Roizman P, Shpitzer
T, Popovtzer A and Feinmesser R: Expression of EGFR and Cerb-B2 as
prognostic factors in cancer of the tongue. Oral Oncol. 40:532–537.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ekberg T, Nestor M, Engström M, Nordgren
H, Wester K, Carlsson J and Anniko M: Expression of EGFR, HER2,
HER3, and HER4 in metastatic squamous cell carcinomas of the oral
cavity and base of tongue. Int J Oncol. 26:1177–1185.
2005.PubMed/NCBI
|
|
26
|
Thai TH, Calado DP, Casola S, Ansel KM,
Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, et
al: Regulation of the germinal center response by microRNA-155.
Science. 316:604–608. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P
and Stoffel M: A pancreatic islet-specific microRNA regulates
insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhai Q, Zhou L, Zhao C, Wan J, Yu Z, Guo
X, Qin J, Chen J and Lu R: Identification of miR-508-3p and
miR-509-3p that are associated with cell invasion and migration and
involved in the apoptosis of renal cell carcinoma. Biochem Biophys
Res Commun. 419:621–626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pan Y, Robertson G, Pedersen L, Lim E,
Hernandez-Herrera A, Rowat AC, Patil SL, Chan CK, Wen Y, Zhang X,
et al: miR-509-3p is clinically significant and strongly attenuates
cellular migration and multi-cellular spheroids in ovarian cancer.
Oncotarget. 7:25930–25948. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yoon S, Han E, Choi YC, Kee H, Jeong Y,
Yoon J and Baek K: Inhibition of cell proliferation and migration
by miR-509-3p that targets CDK2, Rac1, and PIK3C2A. Mol Cells.
37:314–321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Herbst RS: Review of epidermal growth
factor receptor biology. Int J Radiat Oncol Biol Phys. 59 2
Suppl:S21–S26. 2004. View Article : Google Scholar
|
|
32
|
Harris RC, Chung E and Coffey RJ: EGF
receptor ligands. Exp Cell Res. 284:2–13. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Spano JP, Lagorce C, Atlan D, Milano G,
Domont J, Benamouzig R, Attar A, Benichou J, Martin A, Morere JF,
et al: Impact of EGFR expression on colorectal cancer patient
prognosis and survival. Ann Oncol. 16:102–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhen Y, Guanghui L and Xiefu Z: Knockdown
of EGFR inhibits growth and invasion of gastric cancer cells.
Cancer Gene Ther. 21:491–497. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Naik DS, Sharma S, Ray A and Hedau S:
Epidermal growth factor receptor expression in urinary bladder
cancer. Indian J Urol. 27:208–214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boulytcheva IV, Soloviev YN, Kushlinskii
NE and Mahson AN: Expression of molecular markers in the tumor and
survival prognosis in osteosarcoma. Bull Exp Biol Med. 150:237–242.
2010.(In English, Russian). View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Galizia G, Lieto E, Orditura M, Castellano
P, Mura AL, Imperatore V, Pinto M, Zamboli A, De Vita F and
Ferraraccio F: Epidermal growth factor receptor (EGFR) expression
is associated with a worse prognosis in gastric cancer patients
undergoing curative surgery. World J Surg. 31:1458–1468. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Traynor AM, Weigel TL, Oettel KR, Yang DT,
Zhang C, Kim K, Salgia R, Iida M, Brand TM, Hoang T, et al: Nuclear
EGFR protein expression predicts poor survival in early stage
non-small cell lung cancer. Lung Cancer. 81:138–141. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
de Melo Maia B, Fontes AM, Lavorato-Rocha
AM, Rodrigues IS, de Brot L, Baiocchi G, Stiepcich MM, Soares FA
and Rocha RM: EGFR expression in vulvar cancer: Clinical
implications and tumor heterogeneity. Hum Pathol. 45:917–925. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ema A, Waraya M, Yamashita K, Kokubo K,
Kobayashi H, Hoshi K, Shinkai Y, Kawamata H, Nakamura K, Nishimiya
H, et al: Identification of EGFR expression status association with
metastatic lymph node density (ND) by expression microarray
analysis of advanced gastric cancer. Cancer Med. 4:90–100. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nakata Y, Uzawa N, Takahashi K, Sumino J,
Michikawa C, Sato H, Sonoda I, Ohyama Y, Okada N and Amagasa T:
EGFR gene copy number alteration is a better prognostic indicator
than protein overexpression in oral tongue squamous cell
carcinomas. Eur J Cancer. 47:2364–2372. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dai W, Li Y, Zhou Q, Xu Z, Sun C, Tan X
and Lu L: Cetuximab inhibits oral squamous cell carcinoma invasion
and metastasis via degradation of epidermal growth factor receptor.
J Oral Pathol Med. 43:250–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huang HJ, Ping FY, Hu JA and Zhao SF:
Effects of epidermal growth factor receptor gene silencing mediated
by short hairpin RNA on proliferation and apoptosis of human tongue
carcinoma cells. Zhonghua Kou Qiang Yi Xue Za Zhi. 44:365–369.
2009.(In Chinese). PubMed/NCBI
|
